Stephen C. Piscitelli

DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study

Ilise Lombardo, Geetha Ramaswamy, Stephen C. Piscitelli et al. · Alzheimer s & Dementia · 2015 · 656 citations

Neuropsychology, Receptor Antagonist, Neurochemical Biomarkers +20

The Effect of Garlic Supplements on the Pharmacokinetics of Saquinavir

Stephen C. Piscitelli, Aaron H. Burstein, Nada Welden et al. · Clinical Infectious Diseases · 2002 · 429 citations

Garlic Caplets, Active Ingredient, Herbal Medicine +9

Comparative Efficacy and Distribution of Lipid Formulations of Amphotericin B in Experimental<i>Candida albicans</i>Infection of the Central Nervous System

Andreas H. Groll, Neelam Giri, Vidmantas Petraitis et al. · The Journal of Infectious Diseases · 2000 · 367 citations · Full text

Clinical Mycology, Antimicrobial Chemotherapy, Drug Resistance +16

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers

Sherene Min, Ivy Song, Julie Borland et al. · Antimicrobial Agents and Chemotherapy · 2009 · 239 citations · Full text

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

Sherene Min, Louis Sloan, Edwin DeJesus et al. · AIDS · 2011 · 212 citations